tiprankstipranks
Trending News
More News >

Immix Biopharma Holds Annual Meeting, Elects Directors

Story Highlights
Immix Biopharma Holds Annual Meeting, Elects Directors

Don’t Miss TipRanks’ Half-Year Sale

Immix Biopharma ( (IMMX) ) has issued an update.

On June 20, 2025, Immix Biopharma, Inc. held its Annual Meeting where stockholders representing 72.1% of the voting shares were present. During the meeting, the stockholders elected directors to serve until the next annual meeting and ratified the appointment of Crowe LLP as the independent registered public accounting firm for the year ending December 31, 2025.

The most recent analyst rating on (IMMX) stock is a Buy with a $7.00 price target. To see the full list of analyst forecasts on Immix Biopharma stock, see the IMMX Stock Forecast page.

More about Immix Biopharma

Average Trading Volume: 210,574

Technical Sentiment Signal: Buy

Current Market Cap: $62.45M

Learn more about IMMX stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1